NovaBay Pharmaceuticals Rebrands to Stablecoin Development Corp After $134M Investment

Shares of NovaBay Pharmaceuticals surged 19% following the announcement of its strategic pivot and rebranding to Stablecoin Development Corporation. This transformation is backed by a substantial $134 million investment from prominent entities, including Tether Investments and Framework Ventures. As part of its new digital asset focus, the company has acquired 2.06 billion SKY tokens and initiated its first staking rewards. The core strategy now centers on staking yields tied specifically to Sky protocol governance parameters and participation levels. This move marks a definitive exit from the healthcare sector in favor of stablecoin development and crypto asset management. The positive market reaction underscores investor confidence in the company's fundamental shift toward the blockchain ecosystem. Industry analysts expect the rebranding and massive capital injection to drive sustained speculative interest in the company’s new operational model.